Read against NIH primary pages on 2026-10-26 · 14 min read

NIH R01 and R21 Deadlines 2026: Standard Due Dates, the Resubmission Shift, and the Review-to-Award Timeline

Read on 2026-10-26 Next read: January 2027, before the Feb 5, 2027 date
Bottom line up front

Almost every guide to National Institutes of Health (NIH) deadlines makes the same mistake: it lists three dates in isolation and stops. That leaves applicants asking the questions the date list never answers. Why is the resubmission deadline a month later? Which cycle does my application actually compete in? When does the money arrive? The honest answer is that NIH funding cycles are not three dates. They are a two-axis system, your activity code (R01, R21, R15, or SBIR) crossed with your application type (new, resubmission, or renewal), read off against three standing cycles that each carry a fixed submission-to-award timeline. This page is the mechanic-explainer: the single canonical view of how the cycles work, why the dates move, and what happens in the 7 to 10 months between a due date and the earliest start. Planning a specific mechanism right now? Run your dates through our NIH deadline calculator before you build a timeline, or read the same dates for the exploratory grant in our NIH R21 deadlines guide.

Editorial standard. This is a deadline-mechanics reference, not medical, legal, or financial advice. Dates and policies change; verify every figure against the primary NIH source linked inline before you submit, and consult your institution's office of sponsored programs for application-specific guidance. We re-read the dates against grants.nih.gov at every review (last read 2026-10-26); no individual credentialed reviewer is named because we do not fabricate credentials.
Table of contents
  1. The funding cycle, drawn to scale
  2. What are the NIH funding cycles?
  3. How do activity code and application type set the date?
  4. Which cycle am I in? Your cycle card
  5. Worked backward-planning example (Cycle I R01)
  6. Why is the resubmission deadline one month later?
  7. What happens between submission and award?
  8. What changed with the AIDS due dates in 2026?
  9. What does "5:00 PM local time" mean for the deadline?
  10. Frequently asked questions
  11. Bottom line
Feb 5
Cycle I new R01 due date (R21 Feb 16, R15 Feb 25)
Mar 5
Cycle I R01 resubmission / renewal date
3
Standard cycles per year (I, II, III)
7-10 mo
Due date to earliest new-R01 start (NIH months, computed)
5:00 PM
Local-time cutoff at applicant org

The funding cycle, drawn to scale

This is the part no date list shows: where the review, the Advisory Council and the earliest start fall after each new-R01 due date, to scale, from the months NIH itself publishes. One month is the same width in every lane, so you can see why February 5 and June 5 are not interchangeable.

New R01 funding cycles to scale: due date, peer review, Advisory Council and earliest start, in months after the due date Cycle I, due February 5: review June to July, Council August or October, earliest start September (7 months) or December (10 months). Cycle II, due June 5: review October to November, Council January, earliest start April (10 months). Cycle III, due October 5: review February to March, Council May, earliest start July (9 months). 0 mo246810 mo months after the due date CYCLE IDue Feb 5new R017 mo (Dec: 10) Review Jun-Jul Start Sep or Start Dec Council Aug or Council Oct CYCLE IIDue Jun 5new R0110 mo to start Review Oct-Nov Start Apr Council Jan CYCLE IIIDue Oct 5new R019 mo to start Review Feb-Mar Start Jul Council May New R01 funding cycles to scale, stacked for a phone: months run down the page from the due date Same data as the wide chart. Cycle I due February 5: review June to July, Council August or October, start September or December. Cycle II due June 5: review October to November, Council January, start April. Cycle III due October 5: review February to March, Council May, start July. 0 mo369 mo CYCLE IDue Feb 5new R01 ReviewJun-Jul Council Aug Start Sep Council Oct or Start Dec CYCLE IIDue Jun 5new R01 ReviewOct-Nov Council Jan Start Apr CYCLE IIIDue Oct 5new R01 ReviewFeb-Mar Council May Start Jul
New-R01 cycles drawn from NIH's published months, read on 2026-10-26. A month is the same length in every lane. Cycle I starts in September (7 months after February 5) or, on NIH's later branch, December (10); Cycle II in April (10 months); Cycle III in July (9 months). Month positions are the first of each published month, so each is good to about a month.
  • Study-section review (NIH-published months)
  • Advisory Council (NIH: may meet the month before or after)
  • Earliest start (a floor, not a forecast)
  • Dashed: NIH's alternative branch

What is fixed and what is not. The due day, the review months, the Council months and the earliest-start months are NIH's own, from its Standard Due Dates page (last updated March 24, 2026, read 2026-10-26). Nothing in the drawing is our estimate. What NIH does not fix: the actual award date. It states that components may not honor requested start dates, so treat every start marker as the earliest door, not the day the money arrives.

Two different numbers; do not mix them. Our 7 to 10 months is a computed floor: the earliest start from NIH's published months. NIAID's page on due dates and review cycles (read 2026-10-26) gives the typical end-to-end figure instead: "After the due date, it typically takes between 8 and 20 months to go through both levels of review and get an award." So 7 to 10 months is the earliest door, and 8 to 20 months is what NIAID says is typical. The same NIAID page confirms the R01 due dates of February 5, June 5 and October 5. It also says "3 months less for AIDS and AIDS-related research"; that wording predates the end of the dedicated AIDS due dates (final date May 7, 2026), so we do not repeat it.

Swipe the table sideways to see every column.

CycleNew R01 dueStudy-section reviewAdvisory CouncilEarliest startDue date to earliest start
Cycle IFeb 5Jun-JulAug or OctSep or Dec7 months (Sep) or 10 (Dec)
Cycle IIJun 5Oct-NovJanApr10 months
Cycle IIIOct 5Feb-MarMayJul9 months
SBIR/STTR Sep 5Sep 5Oct-NovJanApr7 months
SBIR/STTR Jan 5Jan 5Feb-MarMayJul6 months
SBIR/STTR Apr 5Apr 5Jun-JulAugSep or Dec5 months (Sep) or 8 (Dec)

Months are counted from the due day to the first of the published start month and rounded. The SBIR/STTR rows are NIH's separate small-business timeline, which runs 5 to 8 months from due date to earliest start; they are not drawn in the figure because they belong to a different calendar (see our NIH SBIR and STTR guide).

Use this timeline. The figure and the finding are original GrantProbe work computed from NIH's table. Cite it with a link to this page, embed our NIH deadline calculator free with attribution, or licence the tools and data white-label.

GrantProbe, "NIH R01 and R21 Deadlines 2026", https://grantprobe.com/articles/nih-standard-due-dates-funding-cycles-2026, timeline computed from NIH Standard Due Dates, read 2026-10-26.

What are the NIH funding cycles?

The NIH funding cycles are three annual review-and-award cycles, labeled Cycle I, Cycle II, and Cycle III, each of which pairs a submission window with a fixed downstream timeline of peer review, Advisory Council review, and award. Per the NIH Standard Due Dates policy, new R01 applications are due February 5 for Cycle I, June 5 for Cycle II, and October 5 for Cycle III; other mechanisms ride the same cycles on a different day (the R21 on the 16th, the R15 on the 25th), which the matrix below lays out in full. The cycle is not just the date you submit; it is the lane your application rides all the way to the funding decision, and every application competes against others in the same cycle.

The three cycles exist because NIH cannot review tens of thousands of applications continuously. Batching them into quarters lets CSR (the CSR) assign applications to study sections, convene review panels, and feed results into the relevant Advisory Council meeting. The NIAID review-cycle overview from the National Institute of Allergy and Infectious Diseases (NIAID) lays out how the three windows map to cycles I, II, and III. Understanding the cycle is what lets you work backward from the award you want to the date you must submit.

How do activity code and application type set the date?

The NIH due date you owe is the intersection of two axes: your activity code (the grant mechanism) and your application type (new versus resubmission versus renewal). Competitors publish a flat list and leave you to guess which row is yours. The matrix below is the actual decision surface. Read across your mechanism, then down your application type, and the date is the cell where they meet.

Activity codeNew applicationResubmission, renewal or revision
R01 Research ProjectUp to 5 years, 12-page Research StrategyFeb 5 / Jun 5 / Oct 5Mar 5 / Jul 5 / Nov 5
R21 Exploratory2 years, 6-page strategy, no renewalFeb 16 / Jun 16 / Oct 16Mar 16 / Jul 16 / Nov 16
R15 Research EnhancementSame dates for every type; verify the NOFOFeb 25 / Jun 25 / Oct 25Same dates (no shift)
SBIR / STTROwn calendar; same dates for every typeSep 5 / Jan 5 / Apr 5Sep 5 / Jan 5 / Apr 5
The two-axis NIH due-date matrix, read against NIH's Standard Due Dates page on 2026-10-26. All three research mechanisms ride the same Cycle I/II/III months, but the day differs: new R01 applications fall on the 5th, new R21 applications on the 16th (per the Parent R21 PA-25-304), and new R15 applications on the 25th (per the AREA parent R15 NOFO PAR-25-134). R01 resubmissions, renewals, and revisions and R21 resubmissions and revisions shift one month later (R01 to the 5th, R21 to the 16th; R21s cannot be renewed); R15 applications of every type stay on the 25th. SBIR/STTR applications of every type use September 5, January 5 and April 5. Always confirm against the specific notice of funding opportunity.

Which cycle am I in? Your cycle card

Find your row, read your three dates, and take the named next step. Each date is the NIH standard due date for that mechanism and type, read from NIH Standard Due Dates on 2026-10-26; the cycle is the NIH window it falls in (Cycle I covers dates from January 25 to May 7, Cycle II May 25 to September 7, Cycle III September 25 to January 7). It works with no script; with JavaScript each row gets a copy button.

You are filingCycle I / II / III datesEarliest startYour named next step
R01 or U01, newFeb 5 / Jun 5 / Oct 5Sep or Dec / Apr / JulSet an internal draft-complete date 4 weeks before your cycle date, then run it through the calculator.
R01 or U01, resubmission (A1), renewal or revisionMar 5 / Jul 5 / Nov 5Same as the cycle one month earlierUse the extra month on the one-page introduction that answers your summary statement; it does not delay your award.
R21, R03, R33, R34 and related codesNew: Feb 16 / Jun 16 / Oct 16A1, revision: Mar 16 / Jul 16 / Nov 16Sep or Dec / Apr / JulConfirm the date inside your exact NOFO, then read our R21 deadlines guide.
R15, any typeFeb 25 / Jun 25 / Oct 25No resubmission shiftSep or Dec / Apr / JulOpen the date table inside the R15 NOFO you are using, then count back from the 25th.
K awardNew: Feb 12 / Jun 12 / Oct 12A1, revision: Mar 12 / Jul 12 / Nov 12Sep or Dec / Apr / JulCheck whether the date lands on a weekend or holiday (Oct 12, 2026 moves to Oct 13), then confirm in your NOFO.
F fellowshipApr 8 / Aug 8 / Dec 8Same for every typeSep or Dec / Apr / JulTreat the date as final: NOT-OD-26-064 allows no late F applications.
P, R25, T, U54 and similar; R13 conferencesJan 25 / May 25 / Sep 25R13, U13: Apr 12 / Aug 12 / Dec 12Sep or Dec / Apr / JulConfirm in your NOFO; many large-center codes publish their own dates.
SBIR or STTR, any phaseSep 5 / Jan 5 / Apr 5Own small-business timelineApr / Jul / Sep or DecRead the NIH SBIR and STTR guide; late applications are not accepted for small business.

Which date to aim for, by reader type

First R01, draft not finished

If January finds you short, do not rush February 5: a one-day miss there costs 7 months. Aim at June 5 or October 5 instead. The earliest start moves to April or July of the following year, and a miss costs only 3 or 2 months.

Draft complete by early January

Take February 5 (Cycle I). It is the fastest door: 7 months to a September start, or 10 if the award lands on NIH's December branch. Protect it, because it is also the most expensive date to miss.

Revising after a summary statement

Use the shifted date in full (March 5, July 5 or November 5). It does not push your award: you reach the same start as the filer a month earlier. For the January 2027 Council round, NIH has simplified summary statements (see the review note below).

Pilot idea, no preliminary data

The R21 fits: dates on the 16th, 6-page strategy, no preliminary data required, two years and up to $275,000 direct. It cannot be renewed, so plan the R01 that follows from day one.

Teaching-focused institution (R15)

The R15 keeps the 25th for every application type, so an A1 gets no extra month. Count back from February 25, June 25 or October 25 and note that October 25, 2026 moved to October 26.

Small business

SBIR and STTR run their own calendar: 5 to 8 months from due date to earliest start, the fastest in the table, with no late submissions. Do not map it onto the R01 cycles.

Worked backward-planning example: a Cycle I new R01

The matrix gives you a date; the drawing above shows the three cycles side by side, and the table below shows what that date actually buys you, stage by stage, all the way to the money, using the next Cycle I date (February 5, 2027) because the 2026 Cycle I date has already passed. This is the chain you read backward when you have a target start date and need to know which deadline is your real hard wall. Every row is mapped to the cycle structure published on the NIH Standard Due Dates page, which lists Cycle I new R01 receipt as February 5, scientific-merit (peer) review in June or July, Advisory Council in August or October, and the earliest project start in September or December. Where NIH itself publishes a range, this example takes the later branch (October Council, December start), because planning to the later branch never makes you late.

StageWhen (Cycle I, February 2027 filing)What happensSource-verified figure
1. SubmitFeb 5, 2027 (a Friday)New R01 submitted through Grants.gov and validated in eRA Commons by 5:00 PM local time of the applicant org.Cycle I new R01 due date = Feb 5
2. Peer reviewJun / Jul 2027First-level study-section review scores scientific and technical merit and produces the impact score plus summary statement.Cycle I scientific merit review = Jun-Jul
3. Advisory CouncilOct 2027Second-level review at the funding Institute's Advisory Council, which must concur before any award. NIH lists this round as August or October; plan to October.Cycle I Advisory Council = Aug or Oct
4. Earliest award / startDec 2027If funded, the Notice of Award issues and the project may begin. NIH lists the earliest start as September or December; the later branch lines up with the new fiscal year.Cycle I earliest start = Sep or Dec

Net span: about seven months from the February 5 submission to the September branch, and about ten months to the December branch this example plans to. Read it backward: to start a project in December 2027, lock February 5 as your hard deadline, then back up a further two to three weeks for institutional sign-off and time to fix eRA Commons validation errors. Honest hedge: the exact Council month and start date vary by Institute, cycle, and appropriations; NIH publishes August-or-October and September-or-December as ranges and says components may not honor requested start dates, so treat December 2027 as the earliest plausible award on the later branch, not a guaranteed one.

Three structural facts make this matrix legible. First, the mechanisms share the same three cycles but not the same day of the month: a new R01 is due on the 5th (February 5, June 5, October 5), a new R21 on the 16th (February 16, June 16, October 16), and a new R15 on the 25th (February 25, June 25, October 25), per the NIH R01 activity-code page, the NIH R21 activity-code page with Parent R21 PA-25-304, and the NIH R15 activity-code page with AREA parent R15 NOFO PAR-25-134. Second, the resubmission column shifts one month later for R01 and R21 (to March 5 / July 5 / November 5 and March 16 / July 16 / November 16 respectively), but R15 resubmissions stay on the same February 25 / June 25 / October 25 dates as new R15 applications. Third, the mechanism changes the application content even when the cycle matches: the R01 allows a 12-page Research Strategy over a project period of up to five years, while the R21 caps the Research Strategy at six pages, runs two years, requires no preliminary data, and cannot be renewed, as the Parent R21 announcement PA-25-304 spells out.

MechanismProject periodResearch Strategy limitBudget posture
R01 (Research Project Grant)Up to 5 years12 pagesBudgets are not limited but must reflect the actual needs of the project (Parent R01 PA-25-301); the modular format requests up to $250,000 of direct costs per year, per NIH budget guidance
R21 (Exploratory/Developmental)2 years6 pages (NIH page limits)Combined direct costs may not exceed $275,000 over two years; no more than $200,000 in any single year; no preliminary data required, per Parent R21 PA-25-304
R15 (Research Enhancement Award)Up to 3 years12 pagesUp to $375,000 in direct costs for the entire project period of up to 3 years (applications above $250,000 use the R&R budget form), per the AREA parent R15 NOFO PAR-25-134 and the NIH R15 activity code
SBIR / STTRPhase-dependentPer NOFOSBA statutory guidelines; see our NIH SBIR guide

One large-budget rule recently changed in applicants' favor. Historically, requesting $500,000 or more in direct costs in any single year required NIH program-staff approval before submission. That pre-submission approval requirement was eliminated, effective immediately, by Guide Notice NOT-OD-26-019 on December 3, 2025, which also ended NIH's acceptance of letters of intent, removing a planning bottleneck for ambitious budgets. The change does not alter the due dates themselves, but it removes a step that used to force big-budget applicants to start their conversation with program staff even earlier than the timeline below suggests. If you run a startup or small business weighing non-dilutive research dollars against the tax treatment of your own R&D spend, our sister publication CeoCult breaks down the interplay in Section 174 R&D capitalization for software founders.

Why is the resubmission deadline one month later?

The NIH resubmission deadline is one month later than the new-application deadline because NIH deliberately builds in time for applicants to respond to a prior review. Per the standard due dates and the NIAID overview of the R01 process, R01 resubmission (A1), renewal, and revision applications use the shifted dates of March 5, July 5, and November 5, exactly one month after the February 5, June 5, and October 5 new R01 dates (the R21 shift works the same way, one month after the 16th to March 16, July 16, and November 16; the R15 is the exception, with resubmissions on the same February 25, June 25, and October 25 dates as new applications). The extra month exists so that an applicant who received a summary statement from the prior cycle can read the critique, revise the science, and write the one-page introduction that responds to reviewers, all before the resubmission window closes.

This is the single most misunderstood feature of the calendar, and it produces a counterintuitive but important consequence: the later date does not buy you a later review. An A1 submitted by March 5 still competes in Cycle I, alongside the February 5 new applications, and rides the same review-to-award timeline. The month is for revision work, not for delay. A renewal (formerly called a competing continuation) and a revision follow the same one-month-later logic for the same reason: each builds on prior work that needs to be summarized and updated before submission.

Map your exact NIH deadline in 60 seconds

Pick your activity code and application type, and the GrantProbe NIH deadline calculator returns your next standard due date, a live countdown and the cycles after it, with dates that land on a weekend or federal holiday moved to the next business day.

Open the NIH deadline calculator →

What happens between submission and award?

Between submission and award, an NIH application moves through a fixed two-level review sequence, and the earliest start lands 7 to 10 months after a new-R01 due date (the drawing at the top of this page shows all three cycles to scale). The sequence is the same for every mechanism, but the months are not: SBIR/STTR run their own faster calendar. Knowing your own cycle is what turns "I submitted in February" into "I should plan around a fall funding decision." Per the NIH standard due dates table, a Cycle I application undergoes peer review in June or July, reaches Advisory Council in August or October, and can start as early as September or December. Cycle II (due May 25 to September 7) is reviewed in October and November, goes to Council in January and can start in April; Cycle III (due September 25 to January 7) is reviewed in February and March, goes to Council in May and can start in July. Advisory Council meetings may fall in the month before or after the month listed.

Month 0 (Cycle I example)
Submission, Feb 5 or Mar 5

Submit through Grants.gov and validate in eRA Commons before 5:00 PM local time. New applications hit February 5; resubmissions, renewals, and revisions hit March 5. The Center for Scientific Review receives and assigns the application.

~4 months out
Study-section peer review (Jun/Jul)

A study section of subject-matter experts scores the application for scientific and technical merit. This is first-level review and produces the impact score and the summary statement.

~8 months out
Advisory Council review (October)

The funding Institute's Advisory Council conducts second-level review at the October Council meeting. Council must concur before an application can be funded; it weighs program priorities alongside the score.

~9-10 months out
Funding decision and award

The Institute makes the funding decision against its priorities and budget for the fiscal year, then issues the Notice of Award. Plan your project start and staffing around this window, not around the submission date.

What changed in review in 2026 (read 2026-10-26). NOT-OD-26-114 (released September 8, 2026) continues modified peer review for the January 2027 Advisory Council round, which is where Cycle II submissions (the June 5 R01 and July 5 A1 dates of 2026) land. In most meetings 30 to 35 percent of applications are discussed instead of about half; middle-third applications are labeled "competitive but not discussed" and are considered for funding alongside discussed ones; the lowest third are "not competitive and not discussed." Summary statements are simplified to one sentence on committee consensus, bullets on the score-driving points and the three assigned reviewers' critiques, with an overall impact score for discussed applications only. The notice does not touch due dates, cycles or resubmission rules, and it covers only the January 2027 round; we found no notice for the 2027 rounds. Separately, NOT-OD-26-088 (August 14, 2026) is a request for information proposing to report three categories instead of impact scores; comments closed October 13, 2026, it is not policy, and we found no outcome. See the NIH Extramural Nexus explainer.

The practical lesson is to read the calendar backward. If you need funding to start in a given fiscal year, count back seven to ten months from your cycle's earliest start to find the cycle you must hit, then back another few weeks for institutional sign-off and time to fix validation errors. The eRA Commons validation step is where many first-time applicants lose a day they did not budget for, because errors flagged at submission must be corrected before the application is considered on time.

This page is the cycle hub for every NIH mechanism on GrantProbe. For the deep profile of the flagship mechanism, including budget structure, eligibility, and review criteria, see our NIH R01 Research Project Grant profile, which uses these same standard due dates. For the small-business path and its separate receipt calendar, see our NIH SBIR and STTR grants guide.

What changed with the AIDS due dates in 2026?

The biggest live change to the NIH calendar in 2026 is the elimination of the dedicated AIDS application due dates. For decades, AIDS-related applications used a separate, later set of receipt dates from the rest of NIH. That separate calendar is ending. Per NIH Guide Notice NOT-OD-26-029 (released January 28, 2026) and the standard due dates policy, beginning with applications for Advisory Council review in January 2027, which corresponds to due dates on or after May 25, 2026, NIH eliminates dedicated AIDS application due dates, and AIDS-related applications then use the same standard due dates as all other applications. The final AIDS-specific deadline was the Cycle 1 date of May 7, 2026.

Other rules that move your date. A due date that falls on a weekend, a federal holiday or a Washington, D.C. office closure moves to the next business day (so the October 12, 2026 K-award date becomes October 13, and the October 25, 2026 R15 date becomes October 26). Each PI can submit at most six new, renewal, resubmission or revision applications per calendar year (NOT-OD-25-132, T activity codes and R13 excepted). Other mechanisms have their own days: F fellowships April 8, August 8 and December 8; R13 April 12, August 12 and December 12; P, T, R25 and several others January 25, May 25 and September 25.
If you previously used the AIDS calendar. Move your planning to the standard dates for your mechanism (for R01: February 5, June 5, and October 5 for new applications, and March 5, July 5, and November 5 for resubmissions, renewals, and revisions). The separate AIDS receipt dates no longer apply for any cycle that reaches Advisory Council in January 2027 or later. Confirm the exact dates in your specific notice of funding opportunity, because some opportunities set their own special receipt dates regardless of the standard calendar.

The practical effect is a simpler, single calendar. An AIDS-focused investigator who once tracked two sets of dates now tracks one. The trade-off is that the longer preparation window the AIDS calendar historically offered is gone, so investigators who relied on the later dates should rebuild their backward plan around the standard cycle and its seven-to-ten-month path from due date to earliest start.

What does "5:00 PM local time" mean for the deadline?

NIH applications are due by 5:00 PM local time of the applicant organization on the specified due date, per the NIH standard due dates policy. The deadline keys to the time zone of the applicant institution, not to a single national cutoff. A San Francisco institution submits against 5:00 PM Pacific; a Boston institution against 5:00 PM Eastern. This sounds like a generous detail, but it is a trap for multi-site collaborations and for individuals confused about which clock governs.

Because fixing validation errors can take hours, NIH advises submitting well before the deadline rather than at the last legal minute. The submission is not final the moment Grants.gov accepts it; it must pass eRA Commons validation, and any errors must be corrected before the deadline for the application to count as on time. The safest discipline is to treat the deadline as the morning of the due date, not 5:00 PM, so a flagged error does not cost you a full cycle.

Instrumentl Instrumentl keeps the deadlines of the grants you track in one calendar with email alerts; check that it covers the NIH mechanism you need before you rely on it for cycle dates.Partner code GRANTPROBE50: Instrumentl lists it at $50 off (terms at Instrumentl's checkout; read 2026-10-30).
Try Instrumentl Free →

Frequently asked questions

What are the NIH funding cycles?
NIH runs three review-and-award cycles each year, labeled Cycle I, Cycle II, and Cycle III. Each cycle pairs a submission window with a fixed review-and-award timeline. For new R01 and U01 applications the standard due dates are February 5 (Cycle I), June 5 (Cycle II), and October 5 (Cycle III); other mechanisms fall on other days in the same cycles (for example K awards on the 12th, R03 and R21 on the 16th, R15 on the 25th, and SBIR/STTR on September 5, January 5 and April 5). A Cycle I application is peer-reviewed in June or July, goes to Advisory Council in August or October, and can start as early as September or December.
Why is the NIH resubmission deadline one month later than the new-application deadline?
NIH gives resubmission (A1), renewal, and revision applications a one-month-later standard due date so applicants have time to respond to a prior summary statement. For R01 and U01, new applications are due February 5, June 5, and October 5, and resubmissions, renewals, and revisions are due March 5, July 5, and November 5; K awards and the R03/R21 group shift the same way on their own days, while R15, F, R13, P, T, R25 and SBIR/STTR use one set of dates for every application type. The later date does not change the review cycle the application competes in; an A1 submitted by March 5 still reviews in Cycle I alongside the February 5 new applications.
What is the NIH R15 deadline?
The R15 (Research Enhancement Award) uses the standard NIH cycles but its own day of the month: under the AREA parent NOFO PAR-25-134, new, renewal, and resubmission R15 applications are all due February 25, June 25, and October 25. Unlike the R01 and R21, the R15 resubmission date does not shift one month later; resubmissions share the same 25th dates as new applications. Because some R15 funding opportunities set their own specific due dates, always confirm the receipt date inside the exact notice of funding opportunity you plan to use rather than relying on the standing cycle alone.
By what time on the due date must an NIH application be submitted?
NIH applications are due by 5:00 PM local time of the applicant organization on the specified due date, not 5:00 PM Eastern. The deadline keys to the time zone of the applicant institution, so a West Coast organization has its 5:00 PM Pacific cutoff. NIH advises submitting well before the deadline to allow time to correct any errors flagged during the application-validation window.
Did NIH eliminate the AIDS application due dates?
Yes. Beginning with applications for Advisory Council review in January 2027, which means due dates on or after May 25, 2026, NIH eliminated the dedicated AIDS application due dates. AIDS-related and AIDS-nonrelated applications now use the same standard due dates. The final AIDS-specific deadline was the Cycle 1 date of May 7, 2026. Applicants who previously relied on the separate AIDS calendar should move to the standard February 5, June 5, and October 5 framework.
How long does it take to get an NIH award after the due date?
From NIH's published months, the earliest possible start is about 7 months after a Cycle I new R01 date of February 5 (September; 10 months if it starts on the December branch), 10 months after a Cycle II date of June 5 (April) and 9 months after a Cycle III date of October 5 (July). These are floors: NIH notes that components may not honor requested start dates, and NIAID puts the typical wait from due date to award at 8 to 20 months. SBIR/STTR run on their own calendar, 5 to 8 months from due date to earliest start.
What does missing an NIH due date cost?
For a new R01, missing a date by a day moves you to the next cycle, and the earliest possible start slips 7 months if you miss February 5, 3 months if you miss June 5 and 2 months if you miss October 5 (the three always sum to 12). The only relief is the two-week late window in NOT-OD-26-064, for a PD/PI's own extenuating circumstances or NIH review service, and never for F fellowships or SBIR/STTR.
Did NIH change peer review in 2026?
Yes, temporarily. NOT-OD-26-114 (released September 8, 2026) continues modified peer review practices for the January 2027 Advisory Council round: in most meetings 30 to 35 percent of applications are discussed, middle-third applications are labeled competitive but not discussed and still considered for funding, and summary statements are simplified. The notice does not change due dates, cycles or resubmission rules.

Bottom line

NIH funding cycles are not three dates to memorize; they are a two-axis system to read, and a clock to read it against. Cross your activity code (R01, R21, R15, or SBIR) with your application type (new, resubmission, or renewal) and the date falls out: new R01 applications hit February 5, June 5, or October 5, and R01 resubmissions, renewals, and revisions shift one month later to March 5, July 5, or November 5, while other mechanisms keep their own days. The shift exists to give you time to answer a prior review, not to delay it, so an A1 still competes in its original cycle. From submission, plan for roughly seven to ten months through study-section review, the Advisory Council meeting, and the award, and submit before 5:00 PM local time of your own organization. In 2026, the dedicated AIDS due dates end after the final May 7, 2026 date, collapsing two calendars into one. The number worth remembering from our own arithmetic on NIH's table: a one-day miss on a new R01 date costs 7 months of earliest start in Cycle I, 3 in Cycle II and 2 in Cycle III. Run your mechanism through our NIH deadline calculator, then read the full NIH R01 grant profile and our NIH SBIR and STTR guide for mechanism-specific detail.

  1. NIH, Standard Due Dates (Feb 5 / Jun 5 / Oct 5 new; Mar 5 / Jul 5 / Nov 5 resubmission; review, Council and start months for all three cycles; 5:00 PM local-time rule; AIDS due-date elimination; page updated March 24, 2026) read 2026-10-26.
  2. NIAID, Understand Standard Due Dates and Review Cycles (R01 due dates of Feb 5, Jun 5 and Oct 5, and the typical 8 to 20 months from due date to award; read in Chrome 2026-10-26).
  3. NIAID, Overview of the R01 Process (shifted resubmission dates; not readable by our reader on 2026-10-26, the dates are on the NIH Standard Due Dates page).
  4. NIH, Activity Code R21 and Parent R21 PA-25-304 ($275,000 / two-year cap, 6-page strategy, no renewal) .
  5. NIH, Activity Code R01 and Parent R01 PA-25-301 (12-page strategy, up to 5-year project period) .
  6. NIH, Activity Code R15 and AREA parent R15 NOFO PAR-25-134 (up to $375,000 direct over a project period of up to 3 years) .
  7. NIH Guide Notice NOT-OD-26-029, NIH Removing AIDS Application Due Dates from NOFOs (final AIDS deadline May 7, 2026) .
  8. NIH Guide Notice NOT-OD-26-114, Continuation of Modifications to Peer Review Practices (released September 8, 2026; January 2027 Council round) read 2026-10-26.
  9. NIH Guide Notice NOT-OD-26-064, Late Application Submission Policy and End of Continuous Submission (released March 31, 2026) read 2026-10-26.
  10. NIH, Page Limits (R01 12 pages, R15 12 pages, R21 6 pages; page updated September 30, 2026) read 2026-10-26.
  11. NIH Guide Notice NOT-OD-26-088, RFI on Reporting Outcomes from NIH Peer Review (August 14, 2026; comments closed October 13, 2026) read 2026-10-26.

From our network

How to File Taxes as a Freelancer - ceocult.comBest Course Platforms to Sell Online - edubracket.comBest Free Amazon Seller Tools - bagengine.com
☆ Save
Dashboard